8-11 February 2016, Monaco
ITER is the large-scale international scientific experiment that aims to demonstrate the scientific and industrial feasibility of fusion energy for peaceful purposes. The Monaco-ITER International Fusion Energy Days (MIIFED) combined with the ITER Business Forum (IBF) will bring together testimonies and experiences from the world industry about their participation in ITER.
The conference will also review the progress achieved so far, the status of construction and manufacturing, and the upcoming industrial activities. Through B2B and B2C contacts, the event will also stimulate networking and technology transfer.
16 February 2016, Brussels
The FOCUS project consortium has invited ten industrial experts from outside Europe to speak about the current and future research priorities of the European manufacturing sector.
The programme includes sessions on:
The EU funded FOCUS project is part of the Factories of the Future (FoF) initiative and it brings together 11 partners from 5 FoF project clusters to develop methods to improve project exploitation and dissemination.
17-18 February 2016, Brussels
EFFACE project final conference to focus on further action by the EU.
The conference will bring together key stakeholders involved in addressing environmental crime at the local, national, European and international levels including legal, judicial and crime experts; environmental policy experts; EU and Member State policy makers, customs and law enforcement officials; representatives from civil society / NGOs; and others.
The programme will include sessions on:
17-18 February 2016, Barcelona
ALICE RAP project will host an on-site and online final debate to present and discuss key research findings coming out of the project, their policy implications and the science with the greatest potential to contribute to smart and evidence-based global drugs policy.
The event will be attended (either in person or remotely) by high-level scientists, policy actors from national and international organisations and expert civil society actors, and is expected to shape the messages from multidisciplinary addiction science for drug policy influencers and implementers.
Discussions will be stimulated by short scientific presentations on key topics around two broad pillars: